Ligand validation:6B68

9F2: Ceftriaxone

9F2 is a Ligand Of Interest in 6B68 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6B68_9F2_D_400	65%	6%	0.126	0.929	1.87	3.32	7	12	2	0	100%	0.86
6B68_9F2_B_301	54%	4%	0.148	0.913	1.74	3.93	5	13	0	0	100%	0.69
6B68_9F2_A_302	24%	5%	0.196	0.826	1.7	3.85	6	13	0	0	100%	1
6B68_9F2_C_302	17%	4%	0.254	0.83	1.78	4.04	4	12	1	0	100%	1
6B5Y_9F2_D_400	63%	5%	0.153	0.948	1.78	3.85	5	17	0	0	100%	0.92
6B6A_9F2_D_301	56%	4%	0.144	0.916	1.82	4.08	5	13	1	0	100%	0.8
7K8H_9F2_D_301	55%	4%	0.167	0.935	1.93	3.8	12	14	0	0	100%	0.792
6B69_9F2_D_301	39%	6%	0.18	0.885	1.81	3.44	8	13	0	0	100%	0.55
6B6E_9F2_A_302	30%	5%	0.197	0.862	1.82	3.77	7	11	3	0	100%	0.32
6XQV_9F2_A_601	63%	20%	0.129	0.924	0.87	2.64	1	9	0	0	100%	1
5NZX_9F2_A_1102	58%	51%	0.152	0.933	0.83	1.05	1	1	1	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.